Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Blackbird Critical Metals Corp
GMMAF
Primary Symbol:
C.GAMA
Blackbird Critical Metals Corp., formerly Gama Explorations Inc., is a Canada-based mineral exploration company. The Company is focused on the acquisition, exploration and development of mineral properties containing metals used in green technologies and the renewable energy sector. The Company owns 100% interest in the Muskox Lithium Pegmatite Project located within the Yellowknife Pegmatite Province in the Northwest Territories and the Tyee Nickel-Copper Massive Sulphide Project located in North-Eastern Quebec. The Muskox Lithium Pegmatite Project is located in the Northwest Territories, approximately 40 kilometers (km) east of Yellowknife and spans an area of 50 square kilometers (km2). The Tyee Nickel-Copper Massive Sulphide Project is located approximately 130 km north of Havre St. Pierre, Quebec, and 12 km north of Romaine IV Hydroelectric Dam.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
CSE:GAMA - Post by User
Blackbird Critical Metals Corp
<< Previous
Bullboard Posts
Next >>
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Jan 05, 2023 9:56am
183 Views
Post# 35204584
Where is the value here ??? Claims ?
Where is the value here ??? Claims ?
Wow it's so scary to even read the news and price 0.45 for claims , wow it's not for my cash , thanks
Comment on this Post
<< Previous
Bullboard Posts
Next >>
Eminent acquires promising Nevada gold project
Three business reasons companies need to recycle e-waste
Critical materials crisis: Diversifying away from China’s monopoly
Invest wiser with BMO's InvestorLine Platform features
A potential breakthrough in spinal cord and optic nerve injury treatment
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments